No Indian pharma company features in world’s top 20 companies trying to make medicines affordable

Sunday, November 20, 2016

New Delhi: Not even a single Indian pharmaceutical company features in the list of world’s top 20 companies that have attempted at making medicines affordable for those in low and middle income countries, revealed a recent study by the Netherlands-based Access to Medicine Foundation.

Access to Medicine Index 2016

The Access to Medicine Index lists the top-20 companies in the world on the basis of working towards making available essential drugs in low and middle income countries.

The list is topped by UK-headquartered GlaxoSmithKline. Johnson and Johnson, Novartis, Merck, Sanofi, AstraZeneca, Novo Nordisk, Pfizer, Japanese drug maker Daiichi Sankyo are some of the others who have featured in the top-20 list.

The index focuses on 22 diseases, with major on malaria, HIV/AIDS, tuberculosis and viral hepatitis. Some of the parameters used by the report are pricing, R&D, capacity building, actual performance versus intent and innovation, reports BS.

Categories: NEWS, Pharmaceuticals

Tags: , , , , , , , , , , , , , ,

  More from NEWS

Indian pharmaceutical market to reach $56 billion in 2020

India’s ‘first women hospital’ inaugurated in Delhi

Ability to provide sight being shifted from corneal surgeries to newer technologies

Govt may reduce seats in surgical super-speciality courses that fail to attract doctors

New AI able to identify & predict development of cancer symptom clusters

Humira approved in Japan for treatment of Hidradenitis Suppurativa

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> in your comment.